4,5-Difluoro-2-Iodobenzoic Acid | CAS:130137-05-2

We serve 4,5-Difluoro-2-Iodobenzoic Acid CAS:130137-05-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4,5-Difluoro-2-Iodobenzoic Acid

Chemical Name:4,5-Difluoro-2-Iodobenzoic Acid
CAS.NO:130137-05-2
Synonyms:4,5-Difluoro-2-Iodobenzoic Acid
 
Physical and Chemical Properties:
Density 2.1±0.1 g/cm3
Boiling Point 305.7±42.0 °C at 760 mmHg
Molecular Formula C7H3F2IO2
Molecular Weight 283.999
Flash Point 138.7±27.9 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.613
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4,5-Difluoro-2-Iodobenzoic Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,5-Difluoro-2-Iodobenzoic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,5-Difluoro-2-Iodobenzoic Acid Use and application,4,5-Difluoro-2-Iodobenzoic Acid technical grade,usp/ep/jp grade.


Related News: Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.2-Ethyl-5-methylpyrazine manufacturer Doctors have seen fever, coughing and breathing difficulties, which are all to be expected.ETHYL 5-NITROBENZOFURAN-2-CARBOXYLATE supplier Doctors have seen fever, coughing and breathing difficulties, which are all to be expected.2-Bromo-5-(trifluoromethyl)pyridine vendor However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them.A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).